UNC study underscores the potential of the Affordable Care Act to reach many N.C. immigrants
Sixteen years after scientists found the genes that control the circadian clock in all cells, the lab of UNC’s Aziz Sancar, MD, PhD, discovered the mechanisms responsible for keeping the clock in sync.
Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that UNC researcher Zefeng Wang, PhD, discovered is drastically reduced in human lung and breast cancer cells.
Research led by UNC’s Kathleen Caron, PhD, shows that halting the protein CXCR7 leads to over activation of adrenomedullin, a hormone needed at proper levels for normal cardiovascular development
UNC researchers overturn a controversial study about DPP-4 inhibitors – commonly prescribed diabetes medications.
Mark Zylka, PhD, and Lipin Loo, PhD, a postdoctoral fellow in Zylka’s lab, were featured on a recent segment of North Carolina Science Now, a production of UNC-TV.
For the Obama BRAIN Initiative, UNC neuroscientist Spencer Smith, PhD, creates a new kind of microscope to study the brain like never before.
Eight breast cancer genes identified using new approach
Driven by a childhood desire to know what makes us unique, Corey Cusack, PhD, came to UNC to uncover the inner workings of brain cells. This year she earned her doctorate by parsing the tiny proteins involved in neuron death and axon pruning.
For more than 20 years, Sharon Campbell, PhD, has been studying Ras, a protein implicated in 30 percent of all cancers. Now she’s on the hunt for alternative ways to shut the protein down.
Spencer Smith, PhD, received one of 36 NSF grants to create better technologies to advance our knowledge of how the brain works in normal circumstances and in disease states.
The Bamberg Diabetes Transitional Care Study will utilize cutting-edge iPad technology to explore the impact and feasibility of different diabetes interventions for patients transitioning from the hospital to home.
More than half of patients 65 and older were either malnourished or at risk for malnutrition, study finds.
The work, led by researchers at the UNC Lineberger Comprehensive Cancer Center, UNC-Chapel Hill and other TCGA sites, revamps traditional ideas of how cancers are diagnosed and treated and could also have a profound impact on the future landscape of drug development.
This study is believed to be the first to measure attitudes toward e-cigarettes among physicians treating adult smokers.
The finding, detailed in the new journal eLife, shows how the protein GSK-3 is essential for neuronal migration and could be a key player in neurodevelopmental disorders.
Several members of the UNC School of Medicine faculty had articles published in the Journal of the American Medical Association's (JAMA) July 23/30, 2014, HIV/AIDS theme issue.
The grant will allow UNC researchers, led by Samuel McLean, MD, MPH, to perform the first-ever prospective longitudinal study of health outcomes after sexual assault. Graduate students, fellows, or faculty from underrepresented racial and ethnic groups who are interested in potentially developing an NIH Diversity Supplement application related to the study are invited to send a cover letter to the program manager.
By eliminating specific foods from patients’ diets, symptoms improved in 71 percent of patients.
UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies
The study, led by Martina Gentzsch, PhD, provides evidence that could help drug developers improve compounds aimed at correcting CFTR proteins in cystic fibrosis patients.